Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review

Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review

An intranasal formulation of midazolam, Nayzilam, has been FDA-approved to treat intermittent, stereotypic episodes of frequent seizure activity. Nayzilam is easy to administer and can quickly treat seizures that occur outside of the hospital. The intra-nasal route of administration allows non-medic...

Full description

Saved in:
Bibliographic Details
Main Authors: Elyse M. Cornett, Meskerem A. Nemomsa, Bailey Turbeville, Matthew A. Busby, Jessica S. Kaye, Aaron J. Kaye, JooHee Choi, Giovanni F. Ramírez, Giustino Varrassi, Adam M. Kaye, Alan D. Kaye, James Wilson, Latha Ganti
Format: Article
Language:English
Published: Open Medical Publishing 2022-10-01
Series:Health Psychology Research
Online Access:https://doi.org/10.52965/001c.38536
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.52965/001c.38536

Similar Items